university website

W.W. de Herder (Wouter) and S.W.J. Lamberts (Steven)

2004-12-01

Gut endocrine tumours

Publication

Publication

Bailliere's Best Practice & Research. Clinical Endocrinology and Metabolism , Volume 18 - Issue 4 p. 477- 495

Endocrine tumours of the gastrointestinal tract and pancreas may present at different disease stages with either hormonal or hormone-related symptoms/syndromes, or without hormonal symptoms. They may occur either sporadically or as part of hereditary syndromes. In the therapeutic approach to a patient with these tumours, excessive hormonal secretion and/or its effects should always be controlled first. A team approach is needed to achieve a balanced opinion on the use of the different therapeutic options in patients with these tumours.

Additional Metadata
Keywords Carcinoid, Chemoembolization, Chemotherapy, Embolization, Endocrine tumour, Gastrinoma, Insulinoma, Lanreotide, Liver transplantation, Octreotide, Pancreas, Radiotherapy, Somatostatin, Somatostatinoma, VIPoma
Persistent URL doi.org/10.1016/j.beem.2004.08.003, hdl.handle.net/1765/60985
Journal Bailliere's Best Practice & Research. Clinical Endocrinology and Metabolism
Organisation Department of Internal Medicine
Citation
de Herder, W., & Lamberts, S. (2004). Gut endocrine tumours. Bailliere's Best Practice & Research. Clinical Endocrinology and Metabolism (Vol. 18, pp. 477–495). doi:10.1016/j.beem.2004.08.003


User Publication Person Organisation Collection
Close